At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Aug 4, 2026 at 17:30 ET
Two non-C-suite insiders at Xeris Biopharma sold a combined $254K in open-market transactions over a 7-day window. The total value represents just 0.018% of the company's $1.4B market cap, making this a routine and immaterial cluster with no predictive signal.
- Two insiders (Beth Hecht and Kevin McCulloch, both 'See Remarks') sold shares on August 3, 2026.
- Total sale value: $253,793 (Hecht: $133,553; McCulloch: $120,240).
- Sales represent ~0.018% of Xeris's $1.4B market cap, well below the 0.1% materiality threshold.
- Both transactions were open-market sales; no 10b5-1 plan or regular pattern noted.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access